OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
OmniAb's shares outstanding was 129M at Sep 30, 2026. For fiscal 2025 it was 114M, up 11.0% from the year before. The highest annual figure on record is 114M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 114M | +11.0% |
| FY2024 | Dec 31, 2024 | 102M | +2.7% |
| FY2023 | Dec 31, 2023 | 100M | +16.8% |
| FY2022 | Dec 31, 2022 | 85M | +3.3% |
| FY2021 | Dec 31, 2021 | 83M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 129M | +12.7% |
| Q2 FY2026 | Jun 30, 2026 | 129M | +21.3% |
| Q1 FY2026 | Mar 31, 2026 | 128M | +21.4% |
| Q4 FY2025 | Dec 31, 2025 | 128M | +22.0% |
| Q3 FY2025 | Sep 30, 2025 | 115M | +12.0% |
| Q2 FY2025 | Jun 30, 2025 | 106M | +4.6% |
| Q1 FY2025 | Mar 31, 2025 | 106M | +4.8% |
| Q4 FY2024 | Dec 31, 2024 | 105M | +4.7% |
| Q3 FY2024 | Sep 30, 2024 | 102M | +2.5% |
| Q2 FY2024 | Jun 30, 2024 | 101M | +2.0% |
| Q1 FY2024 | Mar 31, 2024 | 101M | +1.6% |
| Q4 FY2023 | Dec 31, 2023 | 100M | +7.2% |
| Q3 FY2023 | Sep 30, 2023 | 100M | +20.9% |
| Q2 FY2023 | Jun 30, 2023 | 99M | +20.4% |
| Q1 FY2023 | Mar 31, 2023 | 99M | +20.0% |
| Q4 FY2022 | Dec 31, 2022 | 93M | +429.4% |
| Q3 FY2022 | Sep 30, 2022 | 83M | +1552.2% |
| Q2 FY2022 | Jun 30, 2022 | 83M | – |
| Q1 FY2022 | Mar 31, 2022 | 83M | – |
| Q3 FY2021 | Sep 30, 2021 | 18M | – |
| Q2 FY2021 | Jun 30, 2021 | 5M | – |